Alteration of myo-inositol monophosphatase in Alzheimer's disease brains

被引：18
|
作者：
Shimohama, S
Tanino, H
Sumida, Y
Tsuda, J
Fujimoto, S
机构：
[1] Kyoto Univ, Fac Med, Dept Neurol, Sakyo Ku, Kyoto 606, Japan
[2] Kyoto Pharmaceut Univ, Dept Environm Biochem, Yamashina Ku, Kyoto 607, Japan
来源：
NEUROSCIENCE LETTERS | 1998年 / 245卷 / 03期
关键词：
myo-inositol monophosphatase; myo-inositol; phospholipid metabolism; brain; human; Alzheimer's disease;
D O I：
10.1016/S0304-3940(98)00209-2
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
myo-Inositol monophosphatase (E.C.3.1.3.25) catalyzes the hydrolysis of myo-inositol 1-phosphate in the presence of Mg2+ at a physiologic pH to form free myo-inositol, maintaining a supply that represents the precursor for inositol phospholipid second messenger signaling systems. In the present study the activity and protein level of myo-inositol monophosphatase were investigated in samples from normal human and Alzheimer's disease (AD) postmortem brains. The separation profile on Sephadex G-100 gel filtration chromatography revealed one major form of myo-inositol monophosphatase in crude extracts from both normal human and AD brains. In AD brains myo-inositol monophosphatase activity and its protein level were significantly higher than in control brains. The activity of myo-inositol monophosphatase per enzyme molecule was similar in control and AD brains. These results suggest that myo-inositol monophosphatase is upregulated in AD, probably reflecting compensatory mechanisms concerned with phospholipid metabolism. (C) 1998 Elsevier Science Ireland Ltd.
引用
收藏
页码：159 / 162
页数：4
相关论文
共 50 条
  • [31] Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2)
    T Yoshikawa
    M Padigaru
    J D Karkera
    M Sharma
    W H Berrettini
    L E Esterling
    S D Detera-Wadleigh
    Molecular Psychiatry, 2000, 5 : 165 - 171
  • [32] Reversible denaturation of myo-inositol monophosphatase. The stability of the metal-binding loop
    Eur J Biochem, 2 (435):
  • [33] Synthesis and structure revision of the myo-inositol monophosphatase inhibitor L-671,776
    Falck, JR
    Reddy, KK
    Chandrasekhar, S
    TETRAHEDRON LETTERS, 1997, 38 (30) : 5245 - 5248
  • [34] High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy
    Gill, R
    Mohammed, F
    Badyal, R
    Coates, L
    Erskine, P
    Thompson, D
    Cooper, J
    Gore, M
    Wood, S
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2005, 61 : 545 - 555
  • [35] Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2)
    Yoshikawa, T
    Padigaru, M
    Karkera, JD
    Sharma, M
    Berrettini, WH
    Esterling, LE
    Detera-Wadleigh, SD
    MOLECULAR PSYCHIATRY, 2000, 5 (02) : 165 - 171
  • [36] Synaptic Polarity Depends on Phosphatidylinositol Signaling Regulated by myo-Inositol Monophosphatase in Caenorhabditis elegans
    Kimata, Tsubasa
    Tanizawa, Yoshinori
    Can, Yoko
    Ikeda, Shingo
    Kuhara, Atsushi
    Mori, Ikue
    GENETICS, 2012, 191 (02) : 509 - U343
  • [37] Synthesis and structure revision of the myo-inositol monophosphatase inhibitor L-671,776
    Tetrahedron Letters, 38 (30):
  • [38] Myo-inositol: A novel biomarker for kidney disease
    Omosule, C.
    Blair, C.
    Herries, E.
    Farnsworth, C.
    Ladenson, J.
    Dietzen, D.
    Gaut, J.
    CLINICA CHIMICA ACTA, 2024, 558
  • [39] Myo-inositol: with or without
    Carlomagno, Gianfranco
    Unfer, Vittorio
    Benvenga, Salvatore
    Nestler, John E.
    ENDOCRINE JOURNAL, 2015, 62 (03) : 297 - 298
  • [40] Myo-Inositol content determined by myo-inositol biosynthesis and oxidation in blueberry fruit
    Song, Fangyuan
    Su, Hongyan
    Yang, Nan
    Zhu, Luying
    Cheng, Jieshan
    Wang, Lei
    Cheng, Xianhao
    FOOD CHEMISTRY, 2016, 210 : 381 - 387
12345